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Lymphoid neoplasms display a wide spectrum ofgrowth patterns in vivo, from
presentation as a solitary extralymphoid tumor, to disseminated involvement of
alllymphoid organs. Sincenormal lymphocytesareuniquely mobile cellsthrough-
out much of their life cycle, it is reasonable to propose that the dissemination of
malignant lymphocytes may reflect their expression ofnormal lymphocyte hom-
ing mechanisms. The migration and traffic of normal lymphocytes to lymph
nodes is controlled in large part by the regulated expression ofsurface receptors
for high endothelial venules (HEV), specialized venules that mediate the extra-
vasation of circulating lymphocytes from the blood into lymphoid organs and
sites of chronic inflammation (reviewed in reference 1). By using a quantitative
in vitro assay of lymphocyte binding to HEV in frozen sections of lymphoid
tissues (2-3), it has been shown that at least two functionally distinct and
independently regulated lymphocyte homing receptor/HEV ligand recognition
systems exist in the mouse, one controlling lymphocyte interactions with HEV
in the mucosal lymphoid organs, Peyer's patches, and the other directing lym-
phocyte traffic to peripheral lymph nodes (4, reviewed in reference 1).
Both functional in vitro assays and immunologic studies with mAbs to putative
homing receptors have confirmed that lymphomas can also express receptors for
HEV (1, 4). The present studies were undertaken to examine whether the
expression of functional homing receptors for HEV might play an important
role in the in vivo behavior of neoplastic lymphocytes. We have compared the
patterns of growth of several HEV-binding and nonbinding murine lymphomas
after passage into syngeneic recipients. The results indicate that the ability to
bind to HEV either regulates the hematogenous dissemination of malignant
lymphocytes to HEV-bearing organs, or is coregulated with factors determining
this metastatic behavior.
Materials and Methods
Lymphomas.
￿
The lymphomas used in these studies are as follows: L1-2, an Abelson
virus-induced C57L lymphoma; RAW112, an Abelson virus-induced BALB/c lym-
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phoma; ABE 8.1/2 (American Type Culture Collection, Rockville, MD), an Abelson-
induced BALB/c lymphoma; EL-4, a chemical carcinogen-induced C57BL lymphoma;
BW5147 (American Type Culture Collection), an AKR T cell lymphoma; TK1, TK2,
TK5, TK52, TK23, TK40, spontaneous AKR/Cum T cell lymphomas; TKJ43, an AKR/J
lymphoma; and BK37, an AKR/Cum B cell lymphoma.
In Vitro Assay ofLymphocyte Binding to HEV.
￿
The ability of lymphoma cells and normal
BALB/c mesenteric node lymphocytes (whose binding defines a relative adherence ratio
[RAR] of unity) to adhere to HEV was determined in vitro as described previously (2, 4).
Lymphoid tissues for sections and control lymphocytes were from 6-8-wk-old BALB/c
mice.
Passage ofLymphomas.
￿
Lymphomas were passaged by injection of 10' to 10' cells into
the right thigh muscle of syngeneic mice. To improve the frequency of successful passage,
most recipients were given 400 rad whole body irradiation 18-24 h before transfer of
cells. Animals were killed 7-28 d later, and the indicated organs were removed and
weighed. Blood, anticoagulated with heparin, was taken for white cell counts. White cell
counts were performed by hemocytometer. Large blasts, infrequent in control blood,
constituted a minimum of 50% and in most cases >80% of the circulating leukocytes in
mice bearing lymphomas.
Histologic Examination of Tissues.
￿
Peyer's patches, spleens, femurs, and selected lymph
nodes from representative recipients of all lymphomas except TK2 and TK52 were
examined histologically to assess involvement by lymphoma. Tissues were fixed in Tellye-
zhinski's fixative and processed routinely for sectioning and staining with hematoxylin
and eosin.
Results and Discussion
Lymphomas were selected for the study because they displayed one or the
other extreme in homing receptor expression (Table I): either failing to bind
detectably to HEV (relative adherence generally <5% of that of control lymph
node cells), or binding extremely well to lymph node HEV, to mucosal HEV in
Peyer's patches, or to both HEV classes (adherence nearly equivalent to or
exceeding that of control mesenteric lymph node lymphocytes on one or both
HEV types).
In Exp. 1, when mice receiving the highest cell dose of syngeneic lymphoma
cellsdeveloped obvious lymphoma (large palpable lymph nodes and/or significant
local mass in the thigh), all animals with detectable local masses or lymph node
enlargement were killed and tumor involvement at the site of injection and in
various lymphoid organs was assessed grossly by weight. Animals without detect-
able disease at that time were allowed to progress further before they were killed.
In Exp. 2, animals receiving various tumor cell doses were killed only when gross
involvement of lymph nodes or massive involvement at the local site developed.
The results, presented in Table I and in Figs. 1 and 2, demonstrate a clear
correlation between the expression of functional HEV-binding ability and the in
vivo metastatic patterns of the transferred lymphomas. HEV-binding lymphomas
uniformly metastasized by the blood to give gross, symmetric enlargement of all
lymph nodes. Peyer's patches were also observed to be enlarged by visual
inspection. Histologically, lymph nodes were replaced by lymphoma cells, and
involvement of Peyer's patches by each of the HEV-binding lymphomas except
BK37 was extensive, with total effacement of the lymphoid architecture. BK37,
a B lineage lymphoma that binds preferentially to peripheral lymph node HEV,
involved Peyer's patches focally leaving much of the architecture of normal
lymphocyte domains intact. Only two of the HEV-binding lymphomas, BK37d
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FIGURE 2 .
￿
Mean values from Exp. 2, summarizing the marked differences in the behavior
ofthe nonbindingandHEV-binding lymphomas .Theperipherallymphnode data (a) represent
the added weights of the salivary lymph nodesand the brachial lymph nodes contralateral to
the injection site . (b) Combined ileocecal mesenteric lymph nodes . (c) Weight oftumor at the
injection site in the right thigh, estimated based on physical measurement of the tumor . (d)
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and in two of six recipients TK40, produced significant local masses at the
injection site.
Nonbinding lymphomas, on the other hand, produced little or no apparent
change in distant lymph node groups or in Peyer's patches. The absence of
involvement of lymph nodes and Peyer's patches was confirmed in histological
examination of tissues from randomly selected recipients of each lymphoma
(except TK2 and TK52, which were not studied histologically). A microscopic
focusoflymphoma wasseen in the mesenteric lymph nodefroma single recipient
of RAW 112. The predominant manifestation of these nonbinding lymphomas
was massive local growth, with enlargement of local lymph nodes draining the
site of tumor cell injection.
The qualitative patterns ofgrowth observed were characteristic ofthe partic-
ular lymphoma transferred, and did not vary substantially with cell dose or with
time (up to 4 wk, the longest period studied). A slight increase in the frequency
of contralateral lymph node (combined axillary and brachial) enlargement in
animals receiving nonbinding lines was apparent in Exp. 1, particularly with the
smallest doses and longest times after injection. In Exp. 2, in which axillary and
brachial nodes were assessed separately, it was clear that this effect was limited
to the axillary lymph node. It probably represented lymphatic spread of lym-
phoma cells across the midline, since in no case were the contralateral salivary
or brachial lymph nodes involved, and axillary node enlargement was only
observed in animals exhibiting extensive and grossly apparent lymphatic dilation
with associated edema. In contrast to the general symmetry exhibited by the
HEV-binding lymphomas, lymph node involvement by the nonbinding lympho-
mas was always asymmetrical.
All lymphomas had access to the bloodstream. Both HEV-binding and non-
binding lines exhibited significantly elevated levels of white blood cells, the
majority of which were blasts (>80% in most cases). More importantly, histologic
involvement ofthe bone marrow was universal, andall lymphomascaused splenic
enlargement, at least in some recipients. Thus the expression of functional
homing receptors for HEV may correlate with the ability of cells that have
successfully entered the blood to extravasate into HEV-bearing organs, rather
than primarily with the capacity of lymphomas to enter the bloodstream.
Although some of the lymphomas exhibited a significant preference for bind-
ing to peripheral lymph node or to mucosal HEV in vitro, all HEV-binding
lymphomas in vivo involved the peripheral lymph nodes, the Peyer's patches,
and the mesenteric lymph nodes (which express both peripheral and mucosal
binding specificities). This may reflect the fact that binding is never completely
specific for one or the other HEV class, or may argue that homing receptor
expression is merely one important component ofa constellation ofco-regulated
phenotypic features that determines the localization and growth of lymphomas.
It should be pointed out, however, that lymphomas TK1 and TK40, which bind
only poorly to peripheral lymph node HEV in vitro, produced a preferential
enlargement ofthemesenteric lymph nodes compared with theperipheral lymph
node-preferential lymphoma BK37 (i.e., the ratio ofweights of the mesenteric
node, which contains HEV capable ofbinding mucosa-specific cells, to peripheral
nodes was greater in the case of the mucosal HEV-specific lines). Furthermore,BARGATZE ET AL.
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all of the lymphomas that bound well to mucosal HEV caused total replacement
of the Peyer's patch architecture histologically, whereas BK37 displayed only
focal involvement. These observations suggest that receptor specificity may play
a quantitative role in determining organ involvement by adoptively transferred
lymphomas. More detailed studies of the kinetics of homing and growth of
passaged lymphomas, and correlation of the initial presentation of lymphomas
with their HEV-binding phenotype, must be undertaken to understand fully the
role of homing receptors in the natural progression and spread of lymphoid
malignancies.
Summary
It has long been postulated that normal lymphocyte homing mechanisms help
determine the metastatic spread of lymphoid neoplasms. The traffic of normal
lymphocytes is controlled in part by the regulated expression of surface receptors
for high endothelial venules (HEV), specialized venules that mediate the extra-
vasation of circulating lymphocytes from the blood into lymphoid organs and
sites of chronic inflammation. Here we have compared the in vivo growth
patterns of HEV-binding vs. nonbinding murine lymphomas passaged intramus-
cularly into syngeneic recipients. We report that lymphomas that bind well to
HEV (as assessed in a quantitative in vitro assay) disseminate widely via the blood,
involving all lymph node groups symmetrically. Although both HEV-binding
and nonbinding lymphomas gain access to the blood, gross involvement of lymph
nodes by nonbinding lymphomas is limited to nodes draining local tumor at the
site of injection, a prominent feature of these lymphomas; distant lymph nodes
are not enlarged. The results suggest that the expression of functional receptors
for HEV either controls the hematogenous dissemination of malignant lympho-
cyte populations to HEV-bearing organs, or is coregulated with factors deter-
mining this metastatic behavior. The findings support the concept that normal
lymphocyte homing mechanisms are important to the spread of leukemias and
lymphomas.
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